Trends in ceftazidime-avibactam activity against multidrug-resistant organisms recovered from respiratory samples of cystic fibrosis patients-Reference-Cited by-同舟云学术

Trends in ceftazidime-avibactam activity against multidrug-resistant organisms recovered from respiratory samples of cystic fibrosis patients

Published:2018-06-25 Issue:5 Volume:20 Page:e12955
ISSN:1398-2273
Container-title:Transplant Infectious Disease
language:en
Short-container-title:Transpl Infect Dis

Author:

Farfour Eric¹^ORCID,Trochu Erwan¹,Devin Clotilde¹,Cardot Martin Emilie¹,Limousin Lucie¹,Roux Antoine²,Picard Clément²,Jolly Emilie¹,Vasse Marc¹,Lesprit Philippe¹

Affiliation:

1. Service de Biologie Clinique; Hôpital Foch; Suresnes France

2. Service de Pneumologie; Hôpital Foch; Suresnes France

Publisher

Wiley

Subject

Infectious Diseases,Transplantation

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/tid.12955/fullpdf

Reference8 articles.

1. Increasing incidence of multidrug resistance among cystic fibrosis respiratory bacterial isolates;Rutter;Microb Drug Resist,2017

2. Burkholderia cepacia complex in Serbian patients with cystic fibrosis: prevalence and molecular epidemiology;Vasiljevic;Eur J Clin Microbiol Infect Dis,2016

3. Ceftazidime-avibactam: an evidence-based review of its pharmacology and potential use in the treatment of Gram-negative bacterial infections;Lagacé-Wiens;Core Evid,2014

4. Overcoming an extremely drug resistant (XDR) pathogen: avibactam restores susceptibility to ceftazidime for Burkholderia cepacia complex isolates from cystic fibrosis patients;Papp-Wallace;ACS Infect Dis,2017

5. Effect of β-Lactamase inhibitors on in vitro activity of β-Lactam antibiotics against Burkholderia cepacia complex species;Everaert;Antimicrob Resist Infect Control,2016

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. In vitro susceptibility of nonfermenting Gram-negative rods to meropenem–vaborbactam and delafloxacin;Future Microbiology;2023-01

2. Activity of Imipenem-Relebactam against Multidrug- and Extensively Drug-Resistant Burkholderia cepacia Complex and Burkholderia gladioli;Antimicrobial Agents and Chemotherapy;2021-10-18

3. Antimicrobial Treatment Strategies for Stenotrophomonas maltophilia: A Focus on Novel Therapies;Antibiotics;2021-10-09

4. Advances in the Microbiology of Stenotrophomonas maltophilia;Clinical Microbiology Reviews;2021-06-16

5. Avibactam potentiated the activity of both ceftazidime and aztreonam against S. maltophilia clinical isolates in vitro;BMC Microbiology;2021-02-22